⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNDX News
Syndax Pharmaceuticals, Inc.
Graft Versus Host Disease (GvHD) Market & Epidemiology Forecast 2026-2036 - Set to Reach New Growth Milestones Through 2036 as Targeted, Cell-Based, and Microbiome Therapies Advance
globenewswire.com
ABBV
JNJ
SNY
INCY
SNDX
NVS
BMY
MRK
REGN
GILD
AMGN
BIIB
AZN
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
SNDX
Syndax Announces Participation in September Investor Conferences
globenewswire.com
SNDX
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
SNDX
Form 8-K
sec.gov
SNDX
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
SNDX
Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
globenewswire.com
SNDX
Form 8-K
sec.gov
SNDX
Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event
globenewswire.com
SNDX
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
SNDX